Clinical trial

Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer

NCT04113096

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-10-01

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2018-10-01Date precision: day

Registry last updated2019-10-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Stage IV Prostate Cancerunresolved

Stage IV Colon Cancerunresolved

Stage IV Breast Cancerunresolved

Stage IV Cancer of the Cervixunresolved

Interventions

Dibenzyl trisulphide capsulesDRUG

Dibenzyl trisulphide capsulesDRUG

Dibenzyl trisulphide capsulesDRUG

Dibenzyl trisulphide capsulesDRUG

Stage IV Breast Cancer PlaceboDRUG

Stage IV: Colon Cancer PlaceboDRUG

Cervical Cancer Stage IV PlaceboDRUG

Cancer of the Prostate PlaceboDRUG

Sponsors & collaborators

The University of The West Indieslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04113096 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.